Back to search
Pure Red Cell Aplasia, Acquired
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pure Red Cell Aplasia, Acquired trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pure Red Cell Aplasia, Acquired trials you may qualify forA phase II trial of a reduced intensity conditioned (RIC) allogeneic hematopoietic cell transplant (HCT) with post-transplant cyclophosphamide (PTCy) for idiopa…
This is a unique clinical and biological database that collects standardized clinical information during the management of all patients with bone marrow failure…
This is an open-label, single-arm study to evaluate the safety and efficacy of bortezomib plus dexamethasone for acquired pure red cell aplasia failure or relap…
This study's goal is to determine the frequency and severity of acute graft versus host disease, to evaluate incidence of primary and secondary graft rejection,…